Lifestyle Interventions for Dementia Prevention
(DDPP Trial)
Trial Summary
The trial requires that you stop using certain psychoactive medications, like tricyclic antidepressants and antipsychotics, within the last 3 months. However, stable doses of some antidepressants like SSRIs and SNRIs are allowed.
Research suggests that the MIND diet, which combines elements of the Mediterranean and DASH diets, is linked to better cognitive function and a lower risk of Alzheimer's disease. Additionally, combining physical activity with the MIND diet may help slow the onset of dementia.
12345The MIND diet, which combines elements of the Mediterranean and DASH diets, has been associated with various health benefits, including better cognitive performance and reduced risk of cardiovascular diseases, without any reported safety concerns in humans.
46789This treatment is unique because it combines aerobic exercise and the MIND diet, which focuses on eating more vegetables, berries, nuts, and fish while reducing meat and sugar intake, to potentially slow the onset of dementia. Unlike drug treatments, this approach targets lifestyle changes, which are modifiable risk factors for dementia.
210111213Eligibility Criteria
This trial is for older African Americans and non-Hispanic whites at risk of cognitive decline, who are sedentary with a poor diet but without significant cognitive impairment or physical disabilities. Participants must not plan extensive travel during the study and be willing to join either lifestyle intervention group.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo an 8-month lifestyle intervention program including aerobic exercise and dietary counseling
Follow-up
Participants are monitored for changes in fitness and cognitive performance